S 15931
S 15931 is a 5-HT1A receptor inhibitor. S 15931 inhibits the late-phase hindpaw licking response induced by formalin and the abdominal writhing response induced by acetic acid in Mus musculus. S 15931 abolishes the spontaneous tail-flick response induced by 8-OH-DPAT in Rattus norvegicus and potentiates the analgesic effect of morphine. S 15931 is applicable for pain-related research.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 153607-45-5
- Fòrmula: C23H28N2O2
- Peso molecular:364.48
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
Ver todos los productos específicos de isoformas 5-HT Receptor
More
Actividad biológica
S 15931 (40 mg/kg; s.c.; single administration; 30 min before testing) inhibits acetic acid-induced writhing response in male NMRI mice[1].
S 15931 (40 mg/kg; s.c.; single administration; 30 min before testing) induces rotarod ataxia in male NMRI mice[1].
S 15931 (40 mg/kg; s.c.; single administration; administered 20 minutes prior to 8-OH-DPAT treatment) potently inhibits the spontaneous tail-flick response induced by 8-OH-DPAT (HY-112061) in male Wistar rats[1].
S 15931 (0-10.0 mg/kg; s.c.; single administration; 60 min before testing) does not alter vocalization threshold on its own, but it enhances the analgesic effect of morphine in a dose-dependent manner in the electrically stimulated tail vocalization test in male Wistar rats, with a significant effect observed at doses ≥0.63 mg/kg[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:NMRI (male, 20-25 g, formalin-induced hindpaw licking model)[1]
-
Dosage:40.0 mg/kg
-
Administration:s.c.; single dose; 30 minutes pre-test
-
Result:Achieved an ID50 of 1.2 mg/kg for inhibition of the early phase of formalin-induced licking, producing a 95% maximum observed effect at 40.0 mg/kg.
Achieved an ID50 of 0.3 mg/kg for inhibition of the late phase of formalin-induced licking, producing a 99% maximum observed effect at 40.0 mg/kg.
-
Animal Model:NMRI (male, 20-25 g, acetic acid-induced abdominal writhing model)[1]
-
Dosage:40.0 mg/kg
-
Administration:s.c.; single dose; 30 minutes pre-test
-
Result:Achieved an ID50 of 10.4 mg/kg for inhibition of acetic acid-induced writhing, producing a 93% maximum observed effect at 40.0 mg/kg.
-
Animal Model:NMRI (male, 20-25 g, rotarod ataxia model)[1]
-
Dosage:40.0 mg/kg
-
Administration:s.c.; single dose; 30 minutes pre-test
-
Result:Achieved an ID50 of 21.3 mg/kg for induction of rotarod ataxia, producing a 90% maximum observed effect at 40.0 mg/kg.
-
Animal Model:Wistar (male, 200-250 g, 8-OH-DPAT-induced spontaneous tail-flicks model)[1]
-
Dosage:40.0 mg/kg
-
Administration:s.c.; single dose; 20 minutes pre-8-OH-DPAT
-
Result:Achieved an ID50 of 0.7 mg/kg for inhibition of 8-OH-DPAT-induced spontaneous tail-flicks, producing a 99% maximum observed effect at 40.0 mg/kg.
-
Animal Model:Wistar (male, 200-250 g, electrical tail stimulation vocalization model)[1]
-
Dosage:0.01, 0.04, 0.16, 0.83, 2.5, 10.0 mg/kg
-
Administration:s.c.; single dose; 60 minutes pre-test
-
Result:Did not significantly alter vocalization threshold relative to vehicle when administered alone.
Dose-dependently facilitated morphine's antinociceptive action, with significant potentiation observed at doses of 0.63 mg/kg, 2.5 mg/kg, and 10.0 mg/kg when co-administered with morphine.
Chemical Information
-
No. CAS 153607-45-5
-
Peso molecular 364.48
-
Fòrmula C23H28N2O2
-
SMILES
C12=CC=CC(N3CCN(CCC4C5=C(CC4)C=CC=C5)CC3)=C1OCCO2
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Powered by Bioz